date:Mar 03, 2014
ieved significant strategic progress in 2013, also demonstrated by an 18% increase in full year EBITDA and strong cash generation, said Feike Sijbesma, CEO/chairman of the DSM Managing Board. We were pleased with the strong performance in Materials Sciences in Q4. Despite the moderate Q4 results in Nutrition, due to currencies and market weakness, DSMs market positions remained strong. This business with its broad, global offering across the value chain is well positioned to benefit from the str